Learn More
Medchemexpress LLC RVX-297 50mg | 1044871-04-6 | 423.50 | C24H29N3O4 | 50 MG

Supplier: Medchemexpress LLC HY11450450MG
RVX-297 is a potent, orally active BD2-selective BET bromodomain inhibitor used in preclinical research to study inflammation and autoimmune disease mechanisms. It preferentially binds BD2 domains of BET proteins and suppresses inflammatory gene expression.
- BD2-selective BET bromodomain inhibitor for mechanistic studies.
- Orally active in preclinical models of inflammation and autoimmunity.
- Potent activity: BRD2(BD2) IC50 = 0.08 μM, BRD3(BD2) = 0.05 μM, BRD4(BD2) = 0.02 μM.
- High purity (95.0%) suitable for in vitro and in vivo research.
- Stable solid: powder storage recommended at low temperatures for long-term stability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.